On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Federación Española de Enfermedades Raras

InstitutionResearch output, impact & collaborations

Federación Española de Enfermedades Raras is a institution indexed in ScholarIQ from OpenAlex.

What is known about Federación Española de Enfermedades Raras?

ScholarIQrecord summary

Federación Española de Enfermedades Raras is a research organisation in Seville, ES. OpenAlex records 675 works and 15,765 citations for it. 233 researchers list it as their most recent affiliation.

How many works does Federación Española de Enfermedades Raras have?

ScholarIQindexed works

Federación Española de Enfermedades Raras has 675 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Federación Española de Enfermedades Raras →

How many citations does Federación Española de Enfermedades Raras have?

ScholarIQcitation count

Federación Española de Enfermedades Raras has 15,765 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Federación Española de Enfermedades Raras →

How many researchers are at Federación Española de Enfermedades Raras?

ScholarIQresearcher count

Federación Española de Enfermedades Raras has 233 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Federación Española de Enfermedades Raras?

ScholarIQavg h-index

Federación Española de Enfermedades Raras has an average h-index of 8 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Federación Española de Enfermedades Raras?

ScholarIQror

The ROR for Federación Española de Enfermedades Raras is on the source record.

Open the ROR →

What is the OpenAlex record for Federación Española de Enfermedades Raras?

ScholarIQopenalex

The OpenAlex for Federación Española de Enfermedades Raras is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Federación Española de Enfermedades Raras?

ScholarIQtop researchers by citations

Juan Carlos Julián Mauro · Dialysis and Renal Disease Management

36 works292 citations

What are the most-cited papers on Federación Española de Enfermedades Raras?

ScholarIQmost cited works

Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Kai‐Uwe Eckardt, Nisha Bansal, Josef Coresh, Marie Evans, Morgan E. Grams, Charles A. Herzog, Matthew T. James, Hiddo J.L. Heerspink, Carol A. Pollock, Paul E. Stevens, Manjula Kurella Tamura, Marcello Tonelli, David C. Wheeler, Wolfgang C. Winkelmayer, Michael Cheung, Brenda R. Hemmelgarn, Ali K. Abu‐Alfa, Shuchi Anand, Mustafa Arici, Shoshana H. Ballew, Geoffrey A. Block, Rafael Burgos-Calderón, David M. Charytan, Zofia Das‐Gupta, Jamie P. Dwyer, Danilo Fliser, Marc Froissart, John S. Gill, Kathryn E Griffith, David C.H. Harris, Kate T. Huffman, Lesley A. Inker, Kitty J. Jager, Min Jun, Kamyar Kalantar‐Zadeh, Bertrand L. Kasiske, Csaba P. Kövesdy, Vera Krane, Edmund J. Lamb, Edgar V. Lerma, Andrew S. Levey, Adeera Levin, Juan Carlos Julián Mauro, Danielle M. Nash, Sankar D. Navaneethan, Dónal O’Donoghue, Gregorio T. Obrador, Roberto Pecoits‐Filho, Bruce Robinson, Elke Schäffner, Dorry L. Segev, Bénédicte Stengel, Peter Stenvinkel, Navdeep Tangri, Francesca Tentori, Yusuke Tsukamoto, Mintu P. Turakhia, Miguel A. Vazquez, Angela Yee‐Moon Wang, Amy W. Williams

Kidney International. 2018117 CitationsOPEN ACCESS

Employment in the patient with chronic kidney disease related to renal replacement therapy.

Juan Carlos Julián Mauro, Molinuevo Tobalina Ja, Sánchez González Jc

PubMed. 201226 Citations

Employment status and indirect costs in patients with renal failure: differences between different modalities of renal replacement therapy.

Juan Carlos Julián Mauro, Jesús Cuervo, Pablo Rebollo, Daniel Callejo

PubMed. 201325 Citations

La situación laboral del paciente con enfermedad renal crónica en función del tratamiento sustitutivo renal

Juan Carlos Julián Mauro, Jesús Á. Molinuevo-Tobalina, Juan C. Sánchez-González

Nefrología. 201224 Citations

Cardiovascular-kidney-metabolic syndrome definition and its role in the prevention, risk staging, and treatment. An opportunity for the Nephrology

Aleix Cases, José Jesús Broseta, María Marqués, Secundino Cigarrán Guldris, Juan Carlos Julián Mauro, Roberto Alcázar Arroyo, Alberto Ortíz

Nefrología (English Edition). 202418 CitationsOPEN ACCESS

How much of the research on Federación Española de Enfermedades Raras is open access?

ScholarIQopen access share

64%OPEN ACCESS

Gold

55%

Green

Hybrid

Bronze

Closed

36%